Pharm NSG 325Exam 1 Study guideExam 1 has 50 multiple-choice questions based on modules 1, 2 and 3. Some of the questions are based on material that was covered in multiple chapters. Chapter# ofquestionsChapter# ofquestionsChapters# ofquestions1 2 11 2 21 32 1 12 1 22 23 0 13 1 23 24 3 14 1 24 35 0 15 1 31 26 1 16 1 32 37 3 17 1 33 28 0 18 1 34 39 2 19 0 35 210 2 20 1 36 2Total 16 10 24Terms: half-life, toxicity, indication, contra-indication, ADR, sympathetic, parasympathetic, agonist, antagonist, sympathomimetic. Tonic-clonic, petit-mal, myoclonic, and atonic movements, tardive dyskinesia, parkinsonism, neuroleptic malignant syndrome, acute dystonia, serotonin syndromeMedications:Epineprhrine, Beta-lockers (end with lol)Phenytoin (Dilantin) with therapeutic blood levelTegretolMAOTCASSRILithium (with therapeutic blood levels)Benzodiazepines- reverse with Flumazenil (Romazacan)BusPar – non benzoLorazapamDiazepamZolpidem (Ambien)Methylphenidate (Ritalin)Atypical geodon, clozaril, respritol, abilify,You will also need to know what labs need to be assessed for medication metabolism or side-effects. Medications that are eliminated through renal system require that renal function be assessed, the lab tests would include: BUN, Cr, creatinine clearance and GFR.Liver function would be assessed by lab tests including: Alkaline Phosphate, ALT – damaged liver function, AST – liver and heart, LDH, and bilirubin. Gtt – liver and functionMedications may impact the way blood is produced or broken down. The lab test to examine them would include a
View Full Document